Menu
Log in



Your Resource for Neurotherapeutics Discovery and Development


  • Home
  • Annual Meeting

Annual Meeting Overview

Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2026) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 2-6, 2026. 

Neurotherapeutics Clinical Trials Course: March 2-3, 2026
Annual Meeting scientific program: March 4-6, 2026

ASENT's 2026 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features 9 symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

2026 Meeting Highlights 

    • 9 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
    • Industry Roundtable
    • CNS Pipeline Presentations
    • Interactive Poster Discussions
    • Sponsored Symposia from Innovation Leaders
    • Live Discussions in Breakout Rooms with Speakers
    • 3rd Annual Neurotherapeutics Clinical Trial Course - LIVE 

    Meeting Location

    Hyatt Regency Bethesda, Bethesda MD

    Who Attends

    30% Academia / 30% Industry / 30% Government / 10% Advocacy

    50% of attendees are practicing physicians

    Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2026 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at a discounted cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 

    Registration Rates

    Cancellation Policy

    You may cancel your registration for a refund through February 1, 2026. Cancellations will be refunded less a $50 cancellation fee. No refunds will be granted for cancellations on February 14, 2026, and after.


    Upcoming events

      • March 02, 2026
      • 8:00 AM
      • March 06, 2026
      • 1:00 PM
      • Hyatt Regency Bethesda, Bethesda, MD
      Register

      ABOUT the MEeting

      Neurotherapeutic Clinical Trials Course: March 2-3, 2026
      ASENT 2026 Annual Meeting: March 4-6, 2026

      The ASENT 2026 Annual Meeting and Clinical Trials Course, the premier neurotherapeutics conference will take place March 2 - 6, 2026 at the Hyatt Regency Bethesda in Bethesda, MD. This scientific meeting is where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

      Advance Program Submit an Abstract Register Clinical Trials Course Exhibit Opportunities


      ASENT's popular Neurotherapeutic Clinical Trials Course runs March 2-3. Followed by the ASENT 2026 Annual Meeting, which runs March 4-6, all in one location.

      Attendees interested in participating in both the Clinical Trials Course and Annual Meeting are encouraged to select the appropriate registration level and then add on the clinical trials course during the registration process for an additional $150.

      The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

      WHO ATTENDS

      Chief Medical Officers | Chief Scientific Officers | Clinician-Investigators | Clinical Research Professionals | Clinical Scientists Clinical Trial Unit Directors CROs | Drug Discovery Neuroscientists  Founders | Funders | Innovation Centers | Investors / Venture Capital | Journal Editors | Medical Directors | MSLs | Patient Advocates | Regulatory Science Professionals | Research Scientists | Trainees (Basic, Clinical, Translational)

    Powered by Wild Apricot Membership Software